Literature DB >> 20234343

Role of chemical stimulation of the duodenum in dyspeptic symptom generation.

O S van Boxel1, J J M ter Linde, P D Siersema, A J P M Smout.   

Abstract

The response to chemical stimuli such as acid, nutrients, and capsaicin at the level of the duodenum is increasingly recognized as important in the etiology of dyspeptic symptoms. Increased duodenal acid exposure has been reported for patients with dyspeptic symptoms. Duodenal hypersensitivity to acid and the enhancing effect of duodenal acid on gastroduodenal mechanosensitivity may also contribute to dyspeptic symptom generation. Serotonergic signaling pathways may be involved in acid-induced dyspeptic symptoms. As for nutrients, lipid has been unequivocally shown to have a function in the pathogenesis of dyspeptic symptoms. Cholecystokinin (CCK) is an important mediator of the effects of duodenal lipid on gastroduodenal sensorimotor activities. It is unclear whether CCK hypersecretion or hypersensitivity to CCK is responsible for symptoms in dyspeptic patients. The presence of capsaicin in the duodenum evokes symptoms and affects gastric sensorimotor function. In patients with dyspepsia, capsaicin-induced symptoms appeared to occur earlier and to be more severe, however the effects of duodenal infusion and putative consequent gastric sensorimotor abnormalities have not been examined. Capsaicin activates transient receptor potential ion channel of the vanilloid type I, which can also be activated and sensitized by acid. The interaction between the different chemical stimuli is complex and has not yet been studied in patients with dyspeptic symptoms. In conclusion, the mechanisms underlying an enhanced response to duodenal chemical stimulation in patients with dyspeptic symptoms are partially understood. At the level of the duodenum, abnormalities may exist in stimulus intensity, mucosal mRNA expression, biosynthesis, release, or inactivation of mucosal mediators, or receptor expression on afferent nerve endings. Elucidation of the abnormalities involved will provide a basis for rational treatment of dyspeptic symptoms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20234343     DOI: 10.1038/ajg.2010.100

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

Review 1.  Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Authors:  Peter Holzer
Journal:  Pharmacol Ther       Date:  2011-03-21       Impact factor: 12.310

2.  Inhibition of gastric perception of mild distention by omeprazole in volunteers.

Authors:  Akihito Iida; Hiroshi Kaneko; Toshihiro Konagaya; Yasushi Funaki; Kentaro Tokudome; Shinya Izawa; Yasuhiro Tamura; Mari Mizuno; Naotaka Ogasawara; Makoto Sasaki; Kunio Kasugai
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

Review 3.  Duodenal Chemosensing of Short-Chain Fatty Acids: Implications for GI Diseases.

Authors:  Mari Iwasaki; Yasutada Akiba; Jonathan D Kaunitz
Journal:  Curr Gastroenterol Rep       Date:  2019-07-10

Review 4.  Duodenal luminal nutrient sensing.

Authors:  Ivar Rønnestad; Yasutada Akiba; Izumi Kaji; Jonathan D Kaunitz
Journal:  Curr Opin Pharmacol       Date:  2014-08-09       Impact factor: 5.547

5.  FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats.

Authors:  Yasutada Akiba; Koji Maruta; Kazuyuki Narimatsu; Hyder Said; Izumi Kaji; Ayaka Kuri; Ken-Ichi Iwamoto; Atsukazu Kuwahara; Jonathan D Kaunitz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-19       Impact factor: 4.052

6.  Duodenal chemosensing and mucosal defenses.

Authors:  Yasutada Akiba; Jonathan D Kaunitz
Journal:  Digestion       Date:  2011-03-10       Impact factor: 3.216

Review 7.  Luminal chemosensing in the duodenal mucosa.

Authors:  Y Akiba; J D Kaunitz
Journal:  Acta Physiol (Oxf)       Date:  2011-01       Impact factor: 6.311

8.  British Society of Gastroenterology guidelines on the management of functional dyspepsia.

Authors:  Christopher J Black; Peter A Paine; Anurag Agrawal; Imran Aziz; Maria P Eugenicos; Lesley A Houghton; Pali Hungin; Ross Overshott; Dipesh H Vasant; Sheryl Rudd; Richard C Winning; Maura Corsetti; Alexander C Ford
Journal:  Gut       Date:  2022-07-07       Impact factor: 31.793

9.  Duodenal epithelial transport in functional dyspepsia: Role of serotonin.

Authors:  Anne-Barbara Witte; Mauro D'Amato; Steen Seier Poulsen; Agneta Laurent; Svend Knuhtsen; Niels Bindslev; Mark Berner Hansen; Peter Thelin Schmidt
Journal:  World J Gastrointest Pathophysiol       Date:  2013-05-15

10.  What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia?

Authors:  Hidekazu Suzuki; Juntaro Matsuzaki; Toshifumi Hibi
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.